Josep Vilaró

691 total citations
15 papers, 354 citations indexed

About

Josep Vilaró is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Josep Vilaró has authored 15 papers receiving a total of 354 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 5 papers in Virology and 5 papers in Epidemiology. Recurrent topics in Josep Vilaró's work include HIV/AIDS Research and Interventions (7 papers), HIV/AIDS drug development and treatment (7 papers) and HIV Research and Treatment (4 papers). Josep Vilaró is often cited by papers focused on HIV/AIDS Research and Interventions (7 papers), HIV/AIDS drug development and treatment (7 papers) and HIV Research and Treatment (4 papers). Josep Vilaró collaborates with scholars based in Spain, United Kingdom and France. Josep Vilaró's co-authors include Lluís Force, Cristina Tural, Bonaventura Clotet, Juan Xu, Joan Carles Monllau, Ramón Cugat, Xavier Cuscó, Àngels Masabeu, Felipe García and Elena Ferrer and has published in prestigious journals such as Resources Conservation and Recycling, AIDS and Clinical Microbiology and Infection.

In The Last Decade

Josep Vilaró

15 papers receiving 337 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Josep Vilaró Spain 11 182 115 98 70 67 15 354
Matthew D. Barnhart United States 15 157 0.9× 196 1.7× 67 0.7× 248 3.5× 30 0.4× 37 644
M Coulibaly Germany 10 67 0.4× 123 1.1× 46 0.5× 104 1.5× 11 0.2× 26 266
Patrick Coghlan Australia 12 39 0.2× 133 1.2× 35 0.4× 120 1.7× 4 0.1× 25 405
L. Noël France 10 17 0.1× 72 0.6× 4 0.0× 107 1.5× 22 0.3× 25 465
Cholenahally Nanjappa Manjunath India 12 18 0.1× 158 1.4× 5 0.1× 212 3.0× 12 0.2× 102 508
Reid W. Draeger United States 13 22 0.1× 114 1.0× 81 0.8× 359 5.1× 22 0.3× 41 523
Rıza Aytaç Çeti̇nkaya Türkiye 8 63 0.3× 42 0.4× 2 0.0× 39 0.6× 37 0.6× 34 271
Muhammad Bilal Pakistan 10 21 0.1× 67 0.6× 2 0.0× 56 0.8× 19 0.3× 44 295
Brendan O’Daly Ireland 13 27 0.1× 50 0.4× 3 0.0× 314 4.5× 34 0.5× 40 559
Francesca Raffi Italy 10 37 0.2× 31 0.3× 4 0.0× 92 1.3× 10 0.1× 32 594

Countries citing papers authored by Josep Vilaró

Since Specialization
Citations

This map shows the geographic impact of Josep Vilaró's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Josep Vilaró with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Josep Vilaró more than expected).

Fields of papers citing papers by Josep Vilaró

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Josep Vilaró. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Josep Vilaró. The network helps show where Josep Vilaró may publish in the future.

Co-authorship network of co-authors of Josep Vilaró

This figure shows the co-authorship network connecting the top 25 collaborators of Josep Vilaró. A scholar is included among the top collaborators of Josep Vilaró based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Josep Vilaró. Josep Vilaró is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Valero, Alicia, et al.. (2020). Raw material use in a battery electric car – a thermodynamic rarity assessment. Resources Conservation and Recycling. 158. 104820–104820. 37 indexed citations
2.
Reyes‐Urueña, Juliana, Colin Campbell, Anna Esteve, et al.. (2018). Estimating the HIV undiagnosed population in Catalonia, Spain: descriptive and comparative data analysis to identify differences in MSM stratified by migrant and Spanish-born population. BMJ Open. 8(2). e018533–e018533. 16 indexed citations
3.
May, Margaret, Urs Widmer, Andrew Phillips, et al.. (2013). Insurability of HIV-positive people treated with antiretroviral therapy in Europe. AIDS. 27(10). 1641–1655. 8 indexed citations
4.
5.
Jaén, Ángeles, Anna Esteve, Josep M. Miró, et al.. (2008). Determinants of HIV Progression and Assessment of the Optimal Time to Initiate Highly Active Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 47(2). 212–220. 44 indexed citations
6.
Navarro, Gemma, María Mercedes Nogueras, F. Segura, et al.. (2008). HIV-1 infected patients older than 50 years. PISCIS cohort study. Journal of Infection. 57(1). 64–71. 32 indexed citations
7.
Martín‐Baranera, Montserrat, Josep Vilaró, Marta Riu, et al.. (2007). Impacto de una intervención de autoevaluación clínica sobre la adecuación de la estancia hospitalaria. Gaceta Sanitaria. 21(4). 290–297. 5 indexed citations
8.
Bonjoch, Anna, Roger Paredes, Peré Domingo, et al.. (2006). Long-Term Safety and Efficacy of Nevirapine-Based Approaches in HIV Type 1-Infected Patients. AIDS Research and Human Retroviruses. 22(4). 321–329. 28 indexed citations
9.
Fuster, Daniel, Ramón Planas, Juan González, et al.. (2006). Results of a Study of Prolonging Treatment with Pegylated Interferon-α2A plus Ribavirin in HIV/HCV-Coinfected Patients with No Early Virological Response. Antiviral Therapy. 11(4). 473–482. 23 indexed citations
10.
Fuster, Daniel, Guadalupe Gómez Melis, Ricard Solà, et al.. (2005). Baseline Factors associated with Haematological Toxicity that Leads to a Dosage Reduction of Pegylated Interferon-α2a and Ribavirin in HIV- and HCV-Coinfected Patients on HCV Antiviral Therapy. Antiviral Therapy. 10(7). 841–847. 17 indexed citations
11.
12.
Fuster, Daniel, Guadalupe Gómez Melis, R. Solà, et al.. (2005). Short communication. Baseline factors associated with haematological toxicity that leads to a dosage reduction of pegylated interferon-alpha2a and ribavirin in HIV- and HCV-coinfected patients on HCV antiviral therapy.. PubMed. 10(7). 841–7. 15 indexed citations
13.
Vilaró, Josep, et al.. (2003). Adecuación de la estancia hospitalaria en un servicio de medicina interna de un hospital comarcal. Revista de Calidad Asistencial. 18(8). 625–627. 3 indexed citations
14.
Cugat, Ramón, et al.. (1993). Osteochondritis dissecans: A historical review and its treatment with cannulated screws. Arthroscopy The Journal of Arthroscopic and Related Surgery. 9(6). 675–684. 73 indexed citations
15.
Sanmartí, Raimón, et al.. (1990). [Arthritis caused by Streptobacillus moniliformis: a case of fever induced by a rat bite].. PubMed. 94(14). 535–7. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Matthew D. Barnhart Breakdown of academic impact, for papers by M Coulibaly Breakdown of academic impact, for papers by Patrick Coghlan Breakdown of academic impact, for papers by L. Noël Breakdown of academic impact, for papers by Cholenahally Nanjappa Manjunath Breakdown of academic impact, for papers by Reid W. Draeger Breakdown of academic impact, for papers by Rıza Aytaç Çeti̇nkaya Breakdown of academic impact, for papers by Muhammad Bilal Breakdown of academic impact, for papers by Brendan O’Daly Breakdown of academic impact, for papers by Francesca Raffi
Rankless by CCL
2026